Ask AI
ProCE Banner Activity

ExpressPoints
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer

Slideset Download
Download this brief summary slideset from a live Webinar to review the rationale for and most recent clinical data on PARP inhibitor combination therapy in metastatic CRPC.

Released: March 03, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only

Faculty Disclosure

Primary Author

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Neal D. Shore, MD, FACS

Head of GU Oncology Center of Excellence
The START Center for Cancer Research
Medical Director
START Carolinas
The START Center for Cancer Research
Myrtle Beach, South Carolina